Loading clinical trials...
Loading clinical trials...
Primary liver cancer is the most common malignant tumor of the liver. Radical surgery is the preferred treatment, but its 5-year recurrence rate is as high as 70%, which is often associated with incom...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhujiang Hospital
NCT07211815 · Primary Liver Cancers
NCT01071941 · Liver Metastases, Primary Liver Cancers
NCT02145013 · Primary Liver Cancers
MI-3DVS
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions